1. Clinical Overview of IrbesartanA New Angiotensin II Receptor Antagonist
2. The New Angiotensin II Receptor Antagonist, IrbesartanPharmacokinetic and Pharmacodynamic Considerations
3. Franc, B.; Hoff, C.; Kiang, S.; Lindrud, M. D.; Monnier, O.; Wei, C.; D, L. M.; Lindrud, D.; Monnier, O. W. C.Novel crystalline structure of irbestan Form A.U.S. Patent 2005032862,2005.
4. Solubility of Irbesartan (Form A) in Different Solvents between 278 K and 323 K
5. Caron, A.; Chantreux, D.; Bouloumie, C.Preparation of new and known tetrazole derivatives - used as angiotensin II antagonists for treating hypertension.U.S. Patent 5629331,1997.